D. Milman et al., UNSUSPECTED UTERINE LEIOMYOSARCOMA DISCOVERED DURING TREATMENT WITH AGONADOTROPIN-RELEASING-HORMONE ANALOG - A CASE-REPORT AND LITERATURE-REVIEW, European journal of obstetrics, gynecology, and reproductive biology, 76(2), 1998, pp. 237-240
We report a case of a 37-year-old woman who had received five courses
of gonadotropin-releasing hormone (GnRH) agonist (Decapeptyl) for pres
umed uterine leiomyomata associated with episodes of uterine bleeding.
Submucous myoma (histologically proven) was partially removed on the
first visit. After a period of significant reduction in the tumor size
and cessation of uterine bleeding, the symptoms recurred along with r
apid re-growth of the uterus. Total abdominal hysterectomy was perform
ed and the pathologic evaluation revealed leiomyosarcoma with a high m
itotic rate. This case and the literature review emphasize the problem
s encountered with the early diagnosis of uterine leiomyosarcoma durin
g GnRH agonist therapy. (C) 1998 Elsevier Science Ireland Ltd.